According to clinical data, full 5-HT1A blockade neither enhances nor cancels the antidepressant effect of fluoxetine in MDD patients suggesting the involvement of other 5-HT receptors (e.g., 5-HT4 receptor). The gene discussed is HTR1A; the disease is major depressive disorder.